Mesco Pharmaceuticals Ltd. reported audited earnings results for the fourth quarter and full year ended March 31, 2017. For the quarter, the company reported loss from operations before other income, finance costs and exceptional items was INR 2,341,854.00 compared to INR 27,347.00 a year ago. Loss from ordinary activities before tax was INR 2,341,854.00 compared to profit from ordinary activities before tax of INR 347,653.00 a year ago. Net loss was INR 2,351,559.00 compared to net profit of INR 241,868.00 a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.12 compared to basic and diluted profit per share before and after extraordinary items of INR 0.01 a year ago. For the full year, the company reported loss from operations before other income, finance costs and exceptional items was INR 2,579,969.00 compared to INR 61,049.00 a year ago. Loss from ordinary activities before tax was INR 2,579,969.00 compared to profit from ordinary activities before tax of INR 313,951.00 a year ago. Net loss was INR 2,589,674.00 compared to net profit of INR 208,166.00 a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.13 compared to basic and diluted profit per share before and after extraordinary items of INR 0.01 year ago.